Trials / Completed
CompletedNCT03669848
Is Transcutaneous Carbon Monoxide Saturation of E-cigarette Users Comparable to That of Smokers?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,116 (actual)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Suspicions of carbon monoxide poisoning that lead to the treatment of victims are numerous. Measurement of transcutaneous carbon monoxide saturation (SpCO) is a useful diagnostic and triage tool for victims and the toxic threshold is clearly defined for both non-smokers (SpCO\> 5%) and smokers ( SpCO\> 10%). Currently, the use of e-cigarettes is democratizing. Unfortunately, the threshold for toxic SpCO is not defined for this patient profile. The risk is treating in excess or worse than underestimating carbon monoxide poisoning in e-cigarette users who would be exposed to carbon monoxide exposure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pulse CO-oximetry | Measuring blood Carbon Monoxide levels with Pulse CO-oximetry (SpCO) |
Timeline
- Start date
- 2018-09-12
- Primary completion
- 2018-09-23
- Completion
- 2018-09-23
- First posted
- 2018-09-13
- Last updated
- 2019-11-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03669848. Inclusion in this directory is not an endorsement.